The most common request in a lower eyelid consultation is some version of the same sentence: I look tired. The most common assumption attached to it is that a syringe will fix it. Sometimes that is true. Often it is not, and the gap between those two situations is the single most useful thing a patient can learn before anyone touches their face.
Here is the problem in one line. Hollowing and bulging are opposite problems, and filler only solves one of them.
A hollow under the eye is a deficit. There is a groove where the lower lid meets the cheek, the skin dips into it, and light falls into that dip and reads as a shadow. Adding volume into a deficit is logical. It is what filler is for. A bulge under the eye is a surplus. Orbital fat that normally sits behind the eye has pushed forward past the retaining structures that used to hold it, and it now sits on top of the bone as a visible mound. Adding volume beneath a surplus does not cancel it. It lifts it. You have taken something that was already heavy and put a cushion under it, and the eye now reads as a shelf: a raised platform with an abrupt edge, rather than a lid that flows into a cheek.
That shelf is the signature of the most common under-eye filler mistake, and it is remarkably hard to talk a patient out of once the syringe is already in the room. So the honest version of this conversation has to happen before that, and it has to start with a diagnosis rather than a product.
Under Eye Surgery or Injectables: The Question Behind the Question
Patients almost never arrive asking for a diagnosis. They arrive asking for a treatment, usually the one a friend had, and usually tear trough rejuvenation, because it is the least frightening option on the menu. That is a reasonable place to start a conversation and a terrible place to end one.
The lower eyelid is the thinnest skin on the body, it sits over a mobile structure, it has almost no subcutaneous fat to disguise anything placed under it, and it is the first part of the face that other people look at. Every one of those facts means the margin for error is smaller here than anywhere else. A millimeter of misplaced product in the mid-cheek is invisible. A millimeter of misplaced product under the eye is a visible ridge in certain light for as long as the product is there, and the section below on longevity will explain why that can be a great deal longer than anyone told you.
So before any decision about dermal fillers or surgery, the question worth answering is narrower and more mechanical: what exactly is producing the appearance you dislike? There are five candidates, they frequently overlap, and each one responds to something different.
The candidates are: true volume loss along the orbital rim, forward herniation of orbital fat, fluid retention, pigment in the skin itself, and skin laxity or crepe texture. Filler addresses the first. Surgery addresses the second. Nothing in an aesthetic clinic reliably addresses the third. Pigment needs a completely separate plan. Texture needs energy or resurfacing, not volume.
You can get a long way toward sorting this out yourself, in a bathroom, in about four minutes.
Five Tests You Can Run on Your Own Face Tonight
These are not a substitute for an examination. They are a way of arriving at one already knowing what you are looking at, which changes the quality of the conversation enormously.
The pinch test. Stand at a mirror in even light. Gently take the skin of the lower lid between finger and thumb, just below the lash line, and lift it away from the eye. Two things can happen. It may lift easily and hold a pleat for a moment before settling, which tells you the skin itself has lost elasticity and there is a laxity component. Or it may resist, feeling tethered and unwilling to come away, which tells you the skin is bound down to deeper structures by the retaining ligaments. Loose skin and tethered skin are not the same problem, and a treatment aimed at one will disappoint in the other. Loose skin sitting over a modest bulge often needs skin addressed directly, whether by radiofrequency microneedling for mild cases or by a surgical skin adjustment for pronounced ones. Tethered skin over a groove is the classic setup for a ligament-driven hollow, which is a different conversation again.
The morning test. This is the one that saves the most money and the most regret. Look at the area within ten minutes of waking, then look again at midday, then again in the evening, and do this on three or four different days. If the puffiness is dramatically worse on waking and has largely settled by lunchtime, what you are looking at is fluid, not fat. Fluid responds to sleep position, salt, alcohol, allergy, sinus congestion, thyroid function, and hydration. It does not respond to filler, and it does not respond to surgery. A patient who has fluid-dominant puffiness and undergoes fat removal has had an irreversible operation for a reversible problem, and will still have puffy mornings afterward. Fat, by contrast, is stubbornly consistent: a herniated fat pad looks the same at eight in the morning and eight at night, because it is a structure rather than a state.
The smile test. Smile broadly and watch what happens to the groove. The tear trough ligament anchors the skin to the bone along the lower orbital rim. When you smile, the cheek rises, and if that ligament is a significant part of your anatomy, the groove will deepen and sharpen rather than smoothing out, because the tissue below is moving up while the tethered line stays put. A groove that becomes more defined on smiling is a ligamentous groove, and ligamentous grooves are where careful, conservative, deeply placed product genuinely earns its reputation. A groove that softens and disappears on smiling is more likely to be a volume or shadow issue and is often better served by cheek support than by injecting directly under the eye at all.
The up and down test. Keep your head still and look up at the ceiling, then down at the floor, watching the lower lid in the mirror. If the bulge becomes more prominent when you look up and recedes when you look down, you are watching orbital fat move with the globe, which confirms that the mound is herniated fat rather than a fixed swelling or a festoon. This one test separates candidates for eyelid surgery from candidates for injectables more reliably than almost anything else a patient can do unaided.
The torch test. Take a phone torch, hold it below the level of your chin, and shine it upward at your face while looking in the mirror. Lighting the area from below eliminates the overhead shadow that normally fills the tear trough. Now look at the color. If the darkness vanishes and the area reads as ordinary skin, you never had dark circles. You had a hollow casting a shadow, and shadow is a geometry problem that volume or surgery can genuinely change. If the darkness persists under upward lighting, the pigment is in the skin or in the vessels beneath it, and no amount of filler will lighten it. Patients who are sold filler for genuine pigment are almost always disappointed, and some are worse off, because a translucent gel under translucent skin can add a gray or blue cast to an area that was already dark.
What Tear Trough Filler Actually Does, and Where It Belongs
When the anatomy is right, hyaluronic acid under the eye is an elegant solution. The right anatomy looks like this: a defined groove along the orbital rim, minimal or no forward fat herniation, reasonable skin thickness and elasticity, no significant fluid component, and realiztic expectations about color.
In that patient, small volumes of a low-hydrophilic, cohesive product placed deep, on periosteum, along the rim, will soften the transition between lid and cheek and remove the shadow. The word doing the work in that sentence is deep. Product placed on the bone is below the muscle and below the thin skin, which is what keeps it from being visible as a lump or as a color change. Product placed superficially in this region, in the interest of an immediately visible result, is what produces the two classic complications discussed further down.
There is also a frequent misdirection worth naming. Many grooves that patients read as an under-eye problem are actually a mid-face problem. The cheek has descended and deflated, the ligament line has become more visible as a result, and the shadow is a downstream consequence. Supporting the cheek, sometimes with a product such as Juvederm placed well below the orbital rim, can resolve the appearance without putting anything into the delicate zone at all. In the right patient, structural restoration with facial fat transfer achieves the same thing with the patient's own tissue, and refinements in micro and nano fat grafting have made very fine placement in thin-skinned areas far more predictable than it once was.
Brow position matters too, and it is chronically ignored in lower lid consultations. A descended lateral brow crowds the upper lid, deepens the appearance of the whole orbital region, and makes the lower lid look worse than it is. Some patients booked for under-eye work are better served by a brow lift, or by nothing at all in the lower lid once the upper third is addressed.
How Long Does Tear Trough Filler Last? Longer Than You Were Told
This is the section that changes minds, and it is the one most consultations skip.
Hyaluronic acid filler is routinely described as lasting six to nine months, or nine to twelve, depending on the product. Those figures come from studies and from clinical experience in the regions where filler is most commonly placed: lips, cheeks, nasolabial folds, jawline. Those are areas with high metabolic turnover, dense vascularity, and constant mechanical movement from chewing, speaking, and expression. Movement and blood flow are what break filler down.
The tear trough has almost none of that. The tissue plane along the orbital rim is comparatively avascular, metabolically quiet, and mechanically still. There is no chewing, no significant stretch, and very little of the constant low-grade motion that degrades product elsewhere in the face. The consequence is that hyaluronic acid placed under the eye can persist dramatically longer than its stated duration. Imaging studies have repeatedly found product still present in the periorbital region years after injection, in patients who were told it would be gone within a year and who genuinely believed it had been.
This has three practical implications, and all three are uncomfortable.
First, a patient who returns at nine months for a top-up because the area no longer looks as good may not be losing product at all. They may be accumulating it. Repeated top-ups on a base of filler that never went away produce a gradual, year-on-year heaviness that neither patient nor injector notices in the moment, because each individual visit adds very little. The face changes on a timescale that a mirror does not report.
Second, the cushioning effect of old product can slowly draw water into the area, since hyaluronic acid is hygroscopic. This is why some patients develop intermittent under-eye puffiness months or years after an injection that initially looked excellent, and why that puffiness fluctuates with salt, sleep, and hormonal cycles in a way that looks and feels exactly like fluid retention. It is fluid retention, held in place by a gel that should have been gone.
Third, and most importantly for anyone considering surgery: old filler changes the surgical field. A surgeon planning lower blepharoplasty on a patient with residual product is operating on tissue whose contour is partly artificial. Honest surgical planning in that situation often begins by dissolving what is there and waiting to see the underlying anatomy without it. There is a fourth implication that matters commercially rather than clinically. Because the accumulation is gradual and the mirror is a poor historian, patients rarely connect the heaviness they eventually dislike with the treatment they have been having for years. They present asking for surgery, or for a stronger version of the same injectable, when the accurate description of their situation is that they are carrying several years of product that never left. Establishing that history honestly, including treatments performed at other practices, is part of the examination rather than an awkward aside at the end of it.
Under Eye Filler Gone Wrong: The Shelf, the Blue, and the Bulge
Three patterns account for most of the corrections requested after under-eye injections, and they are recognizable.
The shelf. This is the mechanical error described at the top of this article. Product has been placed under a herniated fat pad in an attempt to smooth the transition below it. Instead of blending the step, it has raised the entire step, so the lower lid now projects forward as a platform and the junction with the cheek is more, not less, abrupt. In profile and in raking side light it is obvious. Face-on in flattering light it can look acceptable, which is exactly why it gets through a follow-up appointment. The underlying error was diagnostic: this patient never needed volume, they needed the surplus addressed.
The Tyndall effect. When hyaluronic acid sits too superficially beneath very thin skin, it scatters light in a wavelength-dependent way. Shorter blue wavelengths scatter back toward the observer more than longer ones, so the overlying skin takes on a bluish or gray cast. The patient came in complaining of dark circles and now has a darker, cooler-toned band than they started with. Concealer will not sit correctly over it, and the color does not shift with lighting the way a shadow does, which is why the torch test described earlier is worth repeating on anyone who has already been injected. Tyndall is a placement problem, not a product problem, and its only real remedy is removal.
The chronic puff. Product that has attracted water sits as a soft, variable fullness that is worst on waking and never fully resolves. Patients frequently misinterpret this as their own eye bags having worsened with age, and ask for more treatment for a problem that treatment created. Anyone whose under-eye puffiness began after an injection, at any point after it, should have residual product considered as the cause before anything else is planned. Reviewing your own photographs from before the first syringe is more informative than most clinical opinions.
Hyaluronidase: When Dissolving Is the Correct Answer
Hyaluronidase is an enzyme that breaks down hyaluronic acid. It is the reason hyaluronic acid is the only filler class that should be used near the eye at all, and it is the single most valuable safety feature of the category. Any practitioner injecting this region should hold it, know how to use it, and be willing to use it.
It is the right answer in several situations: visible ridging or a shelf that has not settled after an appropriate wait; a Tyndall cast, which will not improve with time; persistent water retention around old product; and as a planning step before lower eyelid surgery in a patient with an injection history. It is also, urgently and without deliberation, the answer in a suspected vascular occlusion, which is the rare but serious complication that makes anatomical knowledge in this region non-negotiable.
Two honest caveats belong in this conversation. Hyaluronidase is not perfectly selective: it acts on the body's own hyaluronic acid as well as the injected product, so the area can look temporarily flatter or more hollow than it did before anything was ever placed. That settles over weeks as native tissue recovers, but patients should be warned rather than surprised. And correction is frequently staged. Product that has been layered over several years may need more than one session to clear, with several weeks between them to judge the true baseline.
A related point of confusion: hyaluronidase dissolves hyaluronic acid, not fat. Patients who have read about fat dissolving injections sometimes ask whether the same approach can be used on an eye bag. It should not be. Deoxycholic acid formulations are not appropriate around the orbit, where tissue is thin, the consequences of inflammation are significant, and the anatomy allows no margin for a diffuse, poorly controlled effect. Orbital fat is a surgical problem.
Eye Bag Surgery Done Properly: Repositioning, Not Removal
If the up and down test showed a bulge that moves with the eye, and the morning test showed it does not change through the day, the honest answer is that no injectable fixes this. It is a surgical problem, and the operation has changed considerably.
The older approach to eye bag removal was straightforward and, for a while, satisfying: open the lower lid from behind, identify the herniated fat pads, and excise them. The bulge disappears immediately. Patients love the early photographs.
The problem appears later. The lower lid and the cheek are a continuous surface, and volume in the lid is part of what holds that surface smooth. Remove the fat and the area flattens, and then, as the face continues to lose volume over the following decade, it keeps going past flat into hollow. The result is the skeletal, sunken, slightly haunted lower lid familiar from patients who had this surgery in an earlier era. The bulge was traded for a groove, and the groove is considerably harder to fix than the bulge was.
Fat repositioning takes the opposite view. Rather than discarding the herniated fat, the surgeon releases the retaining ligament along the orbital rim and redrapes that same fat downward and forward, over the rim, into the groove beneath it. The surplus and the deficit are, anatomically, immediately adjacent to one another. Moving tissue from one into the other addresses both at once and produces a continuous, smooth transition from lid to cheek rather than a corrected bulge sitting above an uncorrected trough.
This is also the operation that best resists time. A repositioned pad continues to provide volume along the rim as the face ages, which is precisely where volume is otherwise lost. Twenty years on, a repositioned lower lid looks like a lid. An over-resected one looks like a skull.
Most of this is done transconjunctivally, from inside the lid, leaving no external incision and not disturbing the muscle that supports lid position. Where skin laxity or texture also needs addressing, that is handled as a separate, deliberate component rather than by pulling skin, whether with a conservative skin adjustment, with fractional CO2 laser resurfacing, or with energy-based tightening. Recovery is more comfortable than most patients expect, and knowing the blepharoplasty recovery timeline in advance removes most of the anxiety attached to the decision.
Dark Circles Under Eyes Treatment: A Separate Problem Entirely
If the torch test did not lighten the area, no discussion of volume applies to you, and a great deal of money is lost every year by patients who were never told that.
True under-eye darkness has a few sources. Pigment within the skin, common in deeper skin tones and often familial, responds to topical tyrosinase inhibitors, disciplined daily sun protection, and carefully selected resurfacing, and it is easily aggravated by aggressive treatment, so conservatism is the whole game. Vascular darkness, where a fine network of vessels shows through very thin skin, responds to thickening the skin rather than to changing what is beneath it, which is where microneedling with radiofrequency and collagen-stimulating approaches belong. Post-inflammatory darkening from chronic rubbing, usually allergic, needs the allergy managed before anything cosmetic will hold.
None of these are filler problems. Some of them are made visibly worse by filler. It is entirely reasonable for the honest answer in a consultation to be that a skincare and laser plan is what will help, and that nothing needs to be injected at all. It is also worth saying plainly that no combination of treatments makes a lower eyelid look like it did at twenty-five, and that the goal in this region is a rested, unremarkable eye rather than a conspicuously treated one. The lower lid is the part of the face where restraint reads as skill and enthusiasm reads as damage, and patients who understand that before they choose tend to be far happier with what they end up choosing.
Getting the Diagnosis Right Before Anything Is Booked
Everything above reduces to a single principle: the lower eyelid punishes treatment chosen before diagnosis, and it punishes it for longer than most patients are warned.
A proper assessment involves looking at the area in more than one light and more than one gaze position, palpating the rim, testing lid tone and snap-back, asking about morning variability, allergy, thyroid function, and sleep, reviewing previous injections honestly including ones performed elsewhere, and looking at old photographs to establish what the face actually used to be. Examining results in an eye treatment gallery is useful here, not as a catalogue of what to request, but as a way of recognizing which of the anatomical patterns described above resembles your own.
Patients searching for tear trough treatment in NYC or on Long Island have no shortage of places willing to inject on the day of the consultation. Fewer will tell them that the correct plan is to dissolve what is already there and wait six weeks, or that their puffiness is fluid and belongs with their physician, or that the operation they need is surgical and should not be attempted with a syringe. A consultation with Dr. Hardik Doshi is built around that diagnostic sequence rather than around a treatment chosen in advance, and for patients weighing options from a distance, a virtual consultation is a sensible first step toward finding out which of the five problems is actually yours.